Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Peter Domenig"'
Autor:
Todd Campbell, Paul J. Chuba, Benjamin Goldman, Judith A. Boura, Jacquelyn Booher, Kyle Verdecchia, Peter Domenig
Publikováno v:
Cureus
Purpose To examine dosimetric and clinical outcomes for Cs-131 radioactive seed implant compared to Pd-103 and I-125. Background/Significance Cs-131 is a novel isotope with relatively short half-life (9.7 days) that may have clinical advantages in se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a19085c61b7bd223e5417e5e3f90393
http://europepmc.org/articles/PMC8532522
http://europepmc.org/articles/PMC8532522
Autor:
Judith A Boura, Benjamin Goldman, Jacquelyn G. Booher, Paul J. Chuba, Scott Sircus, Peter Domenig, Jason Greenlee
Publikováno v:
Cureus
Objective To survey Urologists and Radiation Oncologists in Metropolitan Detroit regarding practice patterns in managing non-metastatic prostate cancer during the pandemic. Methods An online survey was created to capture the perspective of the impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24a06db77642cb4a11152b383b178635
https://doi.org/10.7759/cureus.9648
https://doi.org/10.7759/cureus.9648
Publikováno v:
Journal of Clinical Oncology. 38:375-375
375 Background: A recent large single institutional study reported excellent long-term biochemical control and survival for Cs-131 prostate implant. This isotope has short half-life (9.7 days) with clinical advantages including shorter duration of sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::249f81276e0cabfe4fe84dea5b59fa5e
https://doi.org/10.1200/jco.2020.38.6_suppl.375
https://doi.org/10.1200/jco.2020.38.6_suppl.375